Nu-Med Plus, Inc.
NUMD
$0.032
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 55.80K | 61.40K | 63.30K | 109.30K | 107.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 55.80K | 61.40K | 63.30K | 109.30K | 107.00K |
| Operating Income | -55.80K | -61.40K | -63.30K | -109.30K | -107.00K |
| Income Before Tax | -60.90K | -66.50K | -68.40K | -114.40K | -112.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.06 | -0.07 | -0.07 | -0.11 | -0.11 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -60.90K | -66.50K | -68.40K | -114.40K | -112.10K |
| EBIT | -55.80K | -61.40K | -63.30K | -109.30K | -107.00K |
| EBITDA | -- | -- | -- | -54.80K | -69.40K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 338.59M | 338.59M | 338.59M | 331.10M | 331.10M |
| Average Diluted Shares Outstanding | 338.59M | 338.59M | 338.59M | 331.10M | 331.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |